CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -100.0% | 153 | -99.9% | 0.00% | -100.0% |
| Q1 2022 | $11,644,000 | -12.3% | 211,789 | +5.4% | 0.06% | -9.7% |
| Q4 2021 | $13,278,000 | -18.6% | 200,911 | +3.4% | 0.06% | -27.9% |
| Q3 2021 | $16,303,000 | -32.9% | 194,229 | +1.5% | 0.09% | -37.2% |
| Q2 2021 | $24,280,000 | +17.1% | 191,291 | +1.2% | 0.14% | -2.1% |
| Q1 2021 | $20,726,000 | -23.3% | 188,934 | -0.1% | 0.14% | -31.7% |
| Q4 2020 | $27,012,000 | +101.6% | 189,204 | -0.4% | 0.20% | +62.7% |
| Q3 2020 | $13,399,000 | +15.7% | 189,882 | +14.7% | 0.13% | +4.1% |
| Q2 2020 | $11,585,000 | +118.3% | 165,543 | +9.0% | 0.12% | +72.9% |
| Q1 2020 | $5,307,000 | +2932.6% | 151,815 | +2811.7% | 0.07% | +3400.0% |
| Q3 2019 | $175,000 | +105.9% | 5,214 | +59.7% | 0.00% | +100.0% |
| Q2 2019 | $85,000 | -63.2% | 3,265 | -64.6% | 0.00% | -75.0% |
| Q3 2018 | $231,000 | – | 9,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |